Opti-DHA enteric-coated softgels, provided by Douglas Laboratories, contain a novel ratio of essential omega-3 fatty acids, derived from marine lipid concentrate. Processed by molecular distillation, Opti-DHA is an excellent source of these fatty acids, providing 450 mg of docosahexeanoic acid(DHA) and 150 mg eicosapentaenoic acid(EPA) per serving.
The omega-3 fatty acid EPA is the direct precursor for the anti-inflammatory prostaglandins E1 and E3, whereas DHA is of primary importance for the structural integrity of neuronal membranes. DHA is essential for brain and visual development and is vital throughout pregnancy to support fetal brain growth and formation of the retina and visual cortex. As the most abundant fatty acid in the brain, adequate amounts of DHA are needed throughout infancy and adulthood for ongoing optimal function. Low levels of DHA may adversely influence behavior and mental performance, and have been correlated with changes in disposition, memory loss, and visual and other neurological conditions.
Studies have shown that DHA, along with EPA may play an important role in cardiovascular health. One landmark study, the GISSI-Prevenzione Trial, involved over 11,000 people who had already survived myocardial infarction. This was the first large scale trial that showed supplementation of essential fatty acids significantly lowered the risk of death, and that use of this supplement was safe. Interestingly, this trial used a supplement with a ratio of DHA to EPA of approximately 2:1. This is important to note, as most fish oil products contain more EPA than DHA. The exact reasons for such dramatic benefits with respect to heart disease remains unknown, but may be related in part to the ability of fish oil to reduce inflammation, a process intricately involved in the progression of atherosclerosis. Some researchers believe that the body’s inflammatory response to certain factors, along with a fatty diet, can increase the amount of plaque in the arteries, leading to atherosclerosis. Studies indicate that EPA and DHA can act as precursors for the anti-inflammatory prostaglandins E1 and E3, and decrease the formation of proinflammatory prostaglandin E2 and thromboxane A2. Scientists have also suggested that omega-3 fatty acids can have a direct cardiac effect on arrhythmogenesis. Omega- 3 fatty acids may be able to modify sodium channels by binding to the channel proteins. This could then prevent ischemia-induced ventricular fibrillation and sudden cardiac death.
Additionally, Opti-DHA is enteric-coated, significantly reducing the “fishy” taste sometimes associated with marine lipid supplements.
|Suggested Use||Adults take 2 softgel capsules daily or as directed by physician.|
*Daily Value (DV) not established.
|Name||Douglas Labs, Opti-DHA Enteric Coated 60 Softgel Capsules|
|Serving Size||2 Softgel Capsules|
|Package Description||60 Softgel Capsules|
|Product Type||Corn Free, Dairy Free, Gluten Free, Salt Free, Soy Free, Starch Free, Sugar Free, Wheat Free, Yeast Free|